The popular Osteoporosis drug Boniva used by millions of Americans has been linked to Osteonecrosis of the Jaw (ONJ) or “dead jaw.”
Please Note: Schmidt & Clark, LLP, is no longer accepting Boniva claims. If you feel that you may have a potential case, we urge you to contact another law firm adequately suited to handle your case.
What is the Problem?
Actonel, Fosamax, Boniva, Zometa, and Aredia are all in a class of drugs called bisphosphonates and are commonly marketed as medications to help and prevent or treat bone loss in osteoporosis.
There are over 36 million women who use medications like Boniva to prevent or slow osteoporosis. Since the indication of hormone replacement therapy causing increased risk of heart disease and breast cancer, more women are taking bisphosphonates at an earlier age.
Unfortunately with women taking these drugs at an earlier age and for much longer time spans, they are at an increased risk of developing Osteonecrosis of the Jaw (ONJ).
There have been over 2,400 Fosamax (same class of drugs) patients since 2001 that have reported bone death and jaw bone decay or Osteonecrosis of the Jaw.
In addition, more than 120 patients have suffered from such severe pain and debilitation that they have become bedridden or in need of devices like crutches, walkers and wheelchairs.
Signs and Symptoms of Boniva Induced Osteonecrosis of the Jaw
The typical signs and symptoms of osteonecrosis of the jaw may include pain, swelling or infection of the gums, loosening of the teeth, poor healing of the gums, numbness or a feeling of heaviness in the jaw, drainage and exposed bone. Patients with the least serious form of this condition may not show any symptoms, but in the most serious cases, some patients may require the removal of sections of the jaw.